PCSK9 inhibitors - mechanisms of action

Aust Prescr. 2016 Oct;39(5):164-167. doi: 10.18773/austprescr.2016.060. Epub 2016 Oct 1.

Authors

Michael M Page¹, Gerald F Watts²

Affiliations

¹ PathWest, Laboratory Medicine, Fiona Stanley Hospital, Perth.
² School of Medicine and Pharmacology, University of Western Australia, Royal Perth Hospital.

No abstract available

Keywords: LDL cholesterol; familial hypercholesterolaemia; proprotein convertase subtilisin/kexin type 9.

Publication types

Review